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effect of its flavonolignans. Because of the importance of oxidative stress and mito-
chondrial dysfunction in causing neuronal death, prompted us to investigate the ef-
fects of SM against an in vitro model of reactive oxygen species (ROS) production
in the human neuroblastoma cell line SH-SY5Y. We selected two cytotoxic stimuli,
for one hand, hydrogen peroxide (H2O2)(500 μM), and on the other hand the
combination of 30 μM rotenone plus 10 μM oligomycin-A (R/O) that inhibit mi-
tochondrial respiration complexes I and V, respectively. Cell viability, measured as
MTT reduction, was decreased to 70% in cells treated with H2O2 and to 60% in
cells exposed to R/O. Cell incubation with increasing concentrations of SM (1-
1000 μM) for 24 hr, followed by a 24-hr period with H2O2 (extracellular ROS) or
R/O (intracellular ROS). Maximum protection was achieved with 300 μM SM
(30% protection). Our results showed that R/O and H2O2-induced cytotoxicity in
SH-SY5Y cells was suppressed by treatment with SM. Because, it is recently re-
ported that SM crosses the blood–brain barrier and enters the CNS and it is non-
toxic even at higher doses, this flavonoid may be useful in diseases known to be ag-
gravated by reactive oxygen species and in the development of novel treatments for
neurodegenerative disorders. This work was supported by projects Ref.
BSCHGR58/08(UCM), Ref. No. S2009/AGR-1469(CAM) and Consolider-
Ingenio 2010 No.CSD2007-063(MEC), Spain.
1782 Thymoquinone, a Bioactive Component of Nigella sativa,
Modulates Redox Status and Insulin Secretion from
Pancreatic Beta Cells.
J. P. Gray1, 3,  R. Follmer1,  R. Rebar1,  N. Seeram2 and E. Heart3. 1Science, US
Coast Guard Academy, New London, CT; 2Bioactive Botanical Research Laboratory,
University of Rhode Island, Kingston, RI; 3Cellular Dynamics, Marine Biological
Laboratory, Woods Hole, MA.
Nigella Sativa is a traditional medicine that has been used in the Mediterranean to
treat a variety of disorders, including type 2 diabetes. A primary component of
Nigella sativa extract is thymoquinone which, like Nigella sativa extract, attenuates
diabetes symptoms. The molecular targets and interactions of thymoquinone with
metabolic pathways relevant to glucose-stimulated insulin secretion (GSIS) from
pancreatic β-cells have not yet been identified. Our laboratory previously demon-
strated that low (nM-μM) doses of various quinones such as menadione stimulate
insulin secretion from β-cells, and this action was coupled to the generation of low
levels of H2O2, a putative mediator of GSIS. Here we compared the mechanism of
action of thymoquinone to that of menadione in β-cells. Like menadione, thymo-
quinone induced a dose-dependent increase in the production of H2O2. Unlike
menadione, the redox cycling of thymoquinone was not dependent on the glucose
concentration. Both NADPH and NADH supported the redox cycling of thymo-
quinone in cytosolic and mitochondrial fractions. This was consistent with the abil-
ity of thymoquinone to decrease NADH/NAD+ and NADPH/NADP+ ratios, thus
reducing intracellular redox poise. Thymoquinone-dependent redox cycling activi-
ties were inhibited by diphenylene iodonium, an inhibitor of flavin-containing ox-
idoreductases. Dicoumarol and MAC220, NQO1 inhibitors previously shown to
inhibit menadione-dependent redox cycling, failed to inhibit thymoquinone-de-
pendent redox cycling. Unlike menadione, thymoquinone was found to potentiate
GSIS in a dose-dependent manner at stimulatory glucose (concentrations which
potently stimulate insulin secretion). These data suggest that while the mechanisms
of thymoquinone redox cycling are different than those of menadione, thymo-
quinone retains the ability to regulate both redox status and insulin secretion from
β-cells.
1783 Antioxidant and DPPH-Scavenging Activities of Compounds
and Ethanolic Extract of the Leaf and Twigs of Caesalpinia
bonduc L. Roxb.
O. O. Olubanke1,  O. E. Ogunlana2,  A. T. Lawa1,  J. O. Olagunju3,
A. A. Akindahunsi4 and N. H. Tan5. 1Biological Sciences, Covenant University, Ota,
Nigeria; 2Biological Sciences, Crawford University, Igbesa, Nigeria; 3Medical
Biochemistry, College of Medicine, Lagos State University, Ikeja, Nigeria;
4Biochemistry, Federal University of Technology, Akure, Nigeria; 5State Key Laboratory
of Phytochemistry and Plant Resources, Kunming Institute of Botany, Kunming,
China.
Antioxidant effects of ethanolic extract of Caesalpinia bonduc and its isolated bioac-
tive compounds were evaluated in vitro. The compounds included two new cassane
diterpenes, 1α,7α-diacetoxy-5α,6β-dihydroxyl-cass-14(15)-epoxy-16,12-olide (1)
and 12α-ethoxyl-1α,14β-diacetoxy-2α,5α-dihydroxyl-cass-13(15)-en-16,12-olide
(2); and others, bonducellin (3), 7,4’-dihydroxy-3,11-dehydrohomoisoflavanone
(4), daucosterol (5), luteolin (6), quercetin-3-methyl ether (7) and kaempferol-3-
O-α-L-rhamnopyranosyl-(1Ç2)-β-D-xylopyranoside (8). The antioxidant proper-
ties of the extract and compounds were assessed by the measurement of the total
phenolic content, ascorbic acid content, total antioxidant capacity and 1-1-
diphenyl-2-picryl hydrazyl (DPPH) and hydrogen peroxide radicals scavenging ac-
tivities. Compounds 3, 6, 7 and ethanolic extract had DPPH scavenging activities
with IC50 values of 186, 75, 17 and 102 μg/ml respectively when compared to vita-
min C with 15 μg/ml. On the other hand, no significant results were obtained for
hydrogen peroxide radical. In addition, compound 7 has the highest phenolic con-
tent of 0.81±0.01 mg/ml of gallic acid equivalent while compound 8 showed the
highest total antioxidant capacity with 254.31±3.54 and 199.82±2.78 μg/ml gallic
and ascorbic acid equivalent respectively. Compound 4 and ethanolic extract
showed a high ascorbic acid content of 2.26±0.01 and 6.78±0.03 mg/ml respec-
tively. The results obtained showed the antioxidant activity of the ethanolic extract
of C. bonduc and deduced that this activity was mediated by its isolated bioactive
compounds.
1784 Selective Elimination of Malignant Melanomas through
Autophagic and Mitochondria-Based Mechanisms by the
Antitumor Agent Osw-1.
K. Riaz Ahmed,  C. Garcia-Prieto,  L. Feng and P. Huang. Molecular Pathology,
University of Texas MD Anderson Cancer Center, Houston, TX. Sponsor: M. Smith.
Drug resistance and lack of therapeutic selectivity are two of the biggest challenges
to successful melanoma therapy. Constitutive activation of Extracellular Signal
Regulated Kinase 1/2 (ERK1/2) and subsequent chemoresistance has been reported
in malignant melanomas. ERK1/2 has also been implicated in activation of mito-
chondrial gene expression and regulation of autophagy thus making it an important
therapeutic target.
The natural product, OSW-1, isolated from the bulbs of ivory coast lily, has been
shown to be highly cytotoxic in numerous cancer cell lines with yet undefined
mechanisms of action. Herein, we report our results on the anticancer activity and
selectivity of OSW-1 in malignant melanoma cells and its potential mechanisms of
action.
Our preliminary results demonstrated that OSW-1 was highly effective in killing
tumor cells that are resistant to most of the currently available anticancer drugs,
with IC50 values in sub-nM concentrations. Importantly, OSW-1 preferentially
killed melanoma cells and exerted much lower toxicity to normal melanocytes in
culture. Biochemical analysis revealed that OSW-1 treatment caused damage of the
mitochondrial membrane integrity, leading to a decrease in transmembrane poten-
tial and subsequently initiating cell death, apparently through autophagy. Further
study demonstrated that OSW-1 inhibited ERK1/2 expression in melanoma cells
and caused a significant disturbance of cellular calcium homeostasis, leading to
aberrant calcium-mediated processes including mitochondrial impairment. Based
on these results, we postulate that OSW-1 inhibits ERK1/2 mediated signaling and
triggers mitochondrial damage in cells leading to a significant disturbance of cellu-
lar calcium and cell death through autophagy. This study is of great significance
since ERK1/2 signaling is important to melanoma cell survival and inhibition of
ERK1/2 expression and induction of autophagic cell death by OSW-1 will be criti-
cal to combat therapeutic resistance and enhance drug selectivity.
1785 3-Caffeoyl, 4-Dihydrocaffeoylquinic Acid from Salicornia
herbacea Attenuates High Glucose-Induced Hepatic
Lipogenesis in Human HepG2 Cells.
H. Chun2,  Y. Hwang3, 1,  J. Choi1,  H. Kim1,  Y. Chung3 and H. Jeong1.
1Pharmacy, Chungnam National University, Daejeon, Republic of Korea; 2Korea
Research Institute of Bioscience and Biotechnology, Jeongeup, Republic of Korea;
3International University of Korea, Jinju, Republic of Korea.
3-Caffeoyl, 4-dihydrocaffeoylquinic acid (CDCQ) from Salicornia herbacea has a
variety of pharmacological properties, including antioxidant and anti-inflammatory
and hepatoprotective properties. The aims of our study were to provide new data
on the molecular mechanisms underlying the role of CDCQ in prevention of high
glucose-induced lipid accumulation in human HepG2 cells. We found that CDCQ
suppressed high glucose-induced lipid accumulation in HepG2 cells. CDCQ
strongly inhibited the high glucose-induced FAS expression by modulating
SREBP-1c activation. Moreover, the use of a specific inhibitor or liver kinase B1
(LKB1)-siRNA transfected HepG2 cells showed that CDCQ activated AMP-acti-
vated protein kinase (AMPK) via silent information regulator T1 (SIRT1) or LKB1
in HepG2 cells. These results indicate that CDCQ prevents lipid accumulation by
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blocking the expression of SREBP-1c and FAS through LKB1/SIRT1 and AMPK
activation in HepG2 cells, suggesting that CDCQ is a novel AMPK activator with
a potential role in the prevention obesity.
1786 Effects of Saponins from the Roots of Platycodon
grandiflorum on TGF-β1-Induced Epithelial-Mesenchymal
Transition in in A549 Cells.
C. Ho1,  H. Kim1,  Y. Hwang2,  Y. Chung2 and H. Jeong1. 1Pharmacy, Chungnam
National University, Daejeon, Republic of Korea; 2International University of Korea,
Jinju, Republic of Korea.
Epithelial to mesenchymal transition (EMT) is a key event in the progression of
cancer. EMT is characterized by the loss of epithelial and the gain of mesenchymal
features. Previous studies have revealed that treatment with CKS, saponins from the
roots of Platycodon grandiflorum, significantly reduces metastasis and tumorigene-
sis, but the underlying mode of action has not been elucidated. In this study, we in-
vestigated the inhibitory effect of CKS on transforming growth factor (TGF)-β1-
induced alterations characteristic of EMT in human lung carcinoma cells. We
found that CKS-treated cells displayed inhibited TGF-β1-mediated E-cadherin
down-regulation and Vimentin up-regulation and also retained epithelial morphol-
ogy. Furthermore, TGF-β1-increased Snail expression was reduced by CKS.
Pretreatment of cells with CKS blocked TGF-β1-induced Smad2/3 phosphoryla-
tion and Smad7 down-regulation. CKS inhibited TGF-β1-induced phosphoryla-
tion of Akt, ERK1/2, and glycogen synthase kinase-3β (GSK-3β). Furthermore,
TGF-β1-increased Snail expression was reduced by pharmacology inhibitors of
Akt, ERK1/2, and GSK-3β. These results indicate that pretreatment with CKS in-
hibits the TGF-β1-induced EMT process and prevents TGF-β1-induced transdif-
ferentiation via activation of Akt and ERK1/2 and inactivation of GSK-3β in A549
cells.
1787 Platycodin D Regulates Hepatic Lipogenesis via an AMP-
Activated Protein Kinase Dependent Signaling Pathway in
Human HepG2 Cells.
H. Lee2,  Y. Hwang3, 1,  J. Choi1,  H. Kim1,  Y. Chung3 and H. Jeong1. 1Pharmacy,
Chungnam National University, Daejeon, Republic of Korea; 2Korea Research
Institute of Bioscience and Biotechnology, Daejeon, Republic of Korea; 3International
University of Korea, Jinju, Republic of Korea.
Platycodin D, the saponins from the roots of Platycodon grandiflorum (CKS), has
a variety of pharmacological properties, including anti-hyperlipidemic, antioxidant
and hepatoprotective properties. This study was conducted to suggest the role of
AMP-activated protein kinase (AMPK) pathway in the anti-obesity effect of platy-
codin D. We characterized the underlying mechanism platycodin D’s effects in
HepG2 cells by Western blot and RT-PCR analysis. Platycodin D increased the
phosphorylation of AMPK and acetyl-CoA carboxylase (ACC) in HepG2 cells. Use
of a specific inhibitor showed that platycodin D activated AMPK via SIRT1/cal-
cium/calmodulin-dependent kinase kinase (CaMKK) in HepG2 cells. Taken to-
gether, these data suggest that platycodin D exert improving effects on high glu-
cose-induced lipogenesis by reducing of SREBP-1c and FAS expression via AMPK
activation.
1788 Rutaecarpine Suppresses LPS-Induced Inflammation in
Mouse Macrophages: A Possible Pathway through the
Induction of Heme Oxygenase-1 Expression.
S. Jin1,  Y. Hwang2,  H. Kim2,  J. Choi1,  H. Kim1,  Y. Chung2 and H. Jeong1.
1Pharmacy, Chungnam National University, Daejeon, Republic of Korea;
2International University of Korea, Jinju, Republic of Korea.
Rutaecarpine, a quinazolinocarboline alkaloidal compound, is a natural product
isolated from Evodia rutaecarpa and has various biological and pharmacological ef-
fects, including anti-inflammatory and anti-oxidative properties. In the present
study, we investigated the effect of rutaecarpine against lipopolysaccharide (LPS)-
induced inflammation in RAW264.7 macrophages. Treatment with rutaecarpine
suppressed inducible nitric oxide synthase expression and nitric oxide (NO) pro-
duction by downregulating NF-κB activity in lipopolysaccharide (LPS)-stimulated
RAW264.7 macrophages. Rutaecarpine acts by inducing the expression of heme
oxygenase-1 (HO-1) in a dose- and time-dependent manner. The signaling path-
way involved in rutaecarpine-mediated HO-1 induction included Ca2+/calmod-
ulin-dependent protein kinase II (CaMKII) and extracellular signal regulated ki-
nase 1/2 (ERK1/2). Furthermore, the CaMKII-ERK1/2 cascade targets the
transcription factor, NF-E2-related factor-2 (Nrf2). Taken together, our results
demonstrate that rutaecarpine-induced expression of HO-1 is mediated by the
Ca2+-CaMKII-Nrf-2-HO-1 pathway and inhibits LPS-induced inflammation in
RAW264.7 macrophages.
1789 Cultivated Ginseng Inhibits Tarc Expression by Suppressing
the Activation of NF-κB and STAT1 in Human Keratinocyte
Cells.
B. Park1,  J. Choi1,  J. Choi2,  Y. Chung2 and H. Jeong1. 1Pharmacy, Chungnam
National University, Daejeon, Republic of Korea; 2International University of Korea,
Jinju, Republic of Korea.
Atopic dermatitis (AD) is associated with the paradigm of an allergic T helper (Th)
2-mediated disease, characterized by abnormal IgE production, peripheral
eosinophilia, mast cell activation, as well as Th2 and Th1 cytokine up-regulation in
chronic skin lesions. This study examined the inhibitory effects of cultivated gin-
seng (CG) (Panax ginseng C.A. Meyer) on atopic dermatitis in HaCaT cells. CG,
an herb used in Korean herbal medicine, has been widely used in China and Japan
to treat fatigue and to enhance resistance to many diseases. CG suppressed TNF-
α/IFN-γ-induced TARC, CTACK, and MDC mRNA expression in HaCaT cells.
Additionally, CG inhibited TNF-α/IFN-γ-induced activation of NF-κB and
STAT1. These results indicate that CG inhibits chemokine expression in ker-
atinocytes by suppressing of NF-κB and STAT1 activation.
1790 Mollugin Inhibits Proliferation and Induces Apoptosis by
Inhibiting HER2 Expression in HER2-Overexpressing Breast
and Ovarian Cancer Cells.
M. Do,  T. Tran,  M. Na and H. Jeong. Pharmacy, Chungnam National University,
Daejeon, Republic of Korea.
Overexpression of the HER2 gene causes many cancer types and has been reported
to enhance cell proliferation, tumor growth, angiogenesis, and metastasis. This
study investigated the molecular mechanisms by which mollugin exerts anti-tumor
effect in HER2-overexpressing breast and ovarian cancer cells. Mollugin exhibited
potent inhibitory effects on cancer cell proliferation, especially in HER2-overex-
pressing SK-BR-3 human breast cancer cells and SK-OV-3 human ovarian cancer
cells in a dose- and time-dependent manner. Additionally, caspase-3 activity and
PARP cleavage were significantly upregulated in HER2-overexpressing SK-BR-3
and SK-OV-3 cells treated with mollugin. Mollugin treatment caused a dose-de-
pendent inhibition of HER2 gene expression at the transcriptional level, potentially
in part through suppression of NF-κB activation. Moreover, mollugin inhibits cy-
clin D1 expression by downregulating HER2 activation and consequently reducing
PI3K/Akt signaling. These results suggest that mollugin is a novel modulator of the
HER2 pathway in HER2-overexpressing cancer cells with a potential role in the
treatment and prevention of human breast and ovarian cancer with HER2 overex-
pression.
1791 Multiple Signaling Pathways Involved in Suppression of
MDR1 by Mollugin from Rubica cordifolia.
T. Tran,  H. Kim,  M. Do,  S. Jin,  E. Shim,  H. Han,  M. Na and H. Jeong.
Pharmacy, Chungnam National University, Daejeon, Republic of Korea.
Multidrug resistance (MDR) is known to be a serious problem in cancer treatment
and has been identifed as a negative prognostic factor in malignancies. This study
investigated mollugin, purified from roots of Rubica cordifolia L., down-regulated
MDR1 expression in MCF-7/adriamycin (MCF-7/adr) cells, human breast mul-
tidrug-resistant cancer cell. Mollugin treatment significantly inhibited MDR1 ex-
pression by blocking MDR1 gene transcription. Mollugin treatment also signifi-
cantly increased intracellular accumulation of the fluorescently-tagged P-gp
substrate, rhodamine-123. The suppression of MDR1 promoter activity and pro-
tein expression was mediated through mollugin-induced activation of AMP-acti-
vated protein kinase (AMPK) and inhibited NF-κB as well as CREB activation.
